Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 42 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 10106540

    HDAC6 inhibitors and their uses

    Universität Regensburg · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  2. US 10106569

    Inhibitors of sodium glucose transporter 1 for constipation

    LEXICON PHARMACEUTICALS, INC. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  3. US 10098878

    HIF-2α inhibitors for treating iron overload disorders

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  4. US 10093684

    Substituted imidazo[1,2-a]pyrazines as Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  5. US 10093664

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  6. US 10093629

    Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  7. US 10093668

    Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (Mnk1) and 2 (Mnk2)

    Northwestern University · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  8. US 10093676

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  9. US 10092583

    Imidazopyridines Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  10. US 10092656

    Protease inhibitors having enhanced features

    Nektar Therapeutics · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  11. US 10093686

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  12. US 10085990

    Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  13. US 10080745

    Piericidin bacterial inhibitors

    The Regents of the University of California Santa Cruz · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  14. US 10081632

    Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-α]pyrazine-2-carboxamides as RSK inhibitors

    PHOENIX MOLECULAR DESIGNS · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  15. US 10080740

    Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  16. US 10076521

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  17. US 10077273

    SHMT inhibitors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  18. US 10071976

    Small molecule fatty acid synthase inhibitors

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  19. US 10064844

    Pharmaceutical compositions comprising an aromatse inhibitors

    MEREO BIOPHARMA 2 LIMITED · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted

  20. US 10059668

    LSD1 inhibitors

    Mirati Therapeutics, Inc. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  21. US 10053417

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  22. US 10045990

    ERBB4 inhibitors and methods of use thereof

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  23. US 10047104

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Aurigene Discovery Technologies Limited · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  24. US 10040769

    HDAC inhibitors for the treatment of diabetic peripheral neuropathy

    Regenacy Pharmaceuticals, Inc. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.